The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non–small cell lung cancer

(2014) Ming-Hui Ao et al.   HUMAN PATHOLOGY

p40: A p63 Isoform Useful for Lung Cancer Diagnosis – A Review of the Physiological and Pathological Role of p63

(2012) Ana Rita Nobre et al.   ACTA CYTOLOGICA

Evaluation of Napsin A, Cytokeratin 5/6, p63, and Thyroid Transcription Factor 1 in Adenocarcinoma Versus Squamous Cell Carcinoma of the Lung

(2012) Kenneth Whithaus et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung

(2012) Jin Gu Lee et al.   LUNG CANCER

Napsin A Expression in Lung and Kidney Neoplasia

(2011) Nelson G. Ordóñez   ADVANCES IN ANATOMIC PATHOLOGY

Suppression of lung adenocarcinoma progression by Nkx2-1

(2011) Monte M. Winslow et al.   NATURE

Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens

(2010) Sanjay Mukhopadhyay et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features

(2010) L. M. Solis et al.   CLINICAL CANCER RESEARCH

The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity

(2008) Takayuki Ueno et al.   LABORATORY INVESTIGATION